胃肠动力与功能的诊断：临床医生最新指南
Diagnostics of Gastrointestinal Motility and Function: Update for Clinicians.
作者信息
Mari Amir
机构信息
Gastroenterology Department, Nazareth Hospital, Azrieli Faculty of Medicine, Bar Ilan University, Safed 16100N, Israel.
出版信息
Diagnostics (Basel). 2022 Nov 4;12(11):2698. doi: 10.3390/diagnostics12112698.
Abstract
Disorders of gastrointestinal (GI) tract motility and function are prevalent in the general population and negatively affect quality of life [...].
摘要
胃肠道动力和功能紊乱在普通人群中普遍存在，并对生活质量产生负面影响[……]。
相似文献
1
Diagnostics of Gastrointestinal Motility and Function: Update for Clinicians.胃肠动力与功能的诊断：临床医生最新指南
Diagnostics (Basel). 2022 Nov 4;12(11):2698. doi: 10.3390/diagnostics12112698.
2
Gastrointestinal motility disorders: an update.胃肠动力障碍：最新进展
Dig Dis. 2006;24(3-4):228-42. doi: 10.1159/000092876.
3
Use of Bioelectronics in the Gastrointestinal Tract.生物电子学在胃肠道中的应用。
Cold Spring Harb Perspect Med. 2019 Sep 3;9(9):a034165. doi: 10.1101/cshperspect.a034165.
4
[Chronic motility disorders of the upper gastrointestinal tract in the elderly. Pharmaceutical, endoscopic and operative therapy].[老年人上消化道慢性动力障碍。药物、内镜及手术治疗]
Internist (Berl). 2014 Jul;55(7):852-8. doi: 10.1007/s00108-014-3504-z.
5
Competency based medical education in gastrointestinal motility.基于能力的胃肠动力医学教育
Neurogastroenterol Motil. 2016 Oct;28(10):1460-4. doi: 10.1111/nmo.12835. Epub 2016 Apr 7.
6
Involvement of gut microbiota in the association between gastrointestinal motility and 5‑HT expression/M2 macrophage abundance in the gastrointestinal tract.肠道微生物群在胃肠道蠕动与胃肠道5-羟色胺表达/M2巨噬细胞丰度之间关联中的作用。
Mol Med Rep. 2017 Sep;16(3):3482-3488. doi: 10.3892/mmr.2017.6955. Epub 2017 Jul 12.
7
Gastrointestinal motility disorders in inflammatory bowel diseases.炎症性肠病中的胃肠动力障碍。
World J Gastroenterol. 2014 Jan 7;20(1):37-44. doi: 10.3748/wjg.v20.i1.37.
8
Human prokinetic drugs promote gastrointestinal motility in zebrafish.人类促动力药物可促进斑马鱼的胃肠蠕动。
Neurogastroenterol Motil. 2014 Apr;26(4):589-95. doi: 10.1111/nmo.12306. Epub 2014 Feb 7.
9
A computational approach to understanding gastrointestinal motility in health and disease.一种理解健康与疾病状态下胃肠动力的计算方法。
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:429-32. doi: 10.1109/IEMBS.2011.6090057.
10
Electrical therapies for gastrointestinal motility disorders.用于胃肠动力障碍的电疗法。
Expert Rev Gastroenterol Hepatol. 2017 May;11(5):407-418. doi: 10.1080/17474124.2017.1298441. Epub 2017 Mar 21.
本文引用的文献
1
Advances on Neurogastroenterology and Motility Disorders: Pathophysiology, Diagnostics and Management.神经胃肠病学与动力障碍的进展：病理生理学、诊断与管理
J Clin Med. 2022 May 20;11(10):2911. doi: 10.3390/jcm11102911.
2
The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project).胃肠病学和肝病学的现状与未来：国际 SWOT 分析（GASTROSWOT 项目）。
Lancet Gastroenterol Hepatol. 2022 May;7(5):485-494. doi: 10.1016/S2468-1253(21)00442-8. Epub 2022 Mar 2.
3
Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn.根据 Lyon 共识标准对质子泵抑制剂难治性烧心患者进行检查。
Aliment Pharmacol Ther. 2022 Jun;55(11):1423-1430. doi: 10.1111/apt.16838. Epub 2022 Feb 28.
4
Systematic review with meta-analysis: artificial intelligence in the diagnosis of oesophageal diseases.系统评价与荟萃分析：人工智能在食管疾病诊断中的应用。
Aliment Pharmacol Ther. 2022 Mar;55(5):528-540. doi: 10.1111/apt.16778. Epub 2022 Jan 30.
5
Diagnosis and Management of Achalasia: Updates of the Last Two Years.贲门失弛缓症的诊断与管理：过去两年的进展
J Clin Med. 2021 Aug 16;10(16):3607. doi: 10.3390/jcm10163607.
6
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.根据里昂共识，新型阻抗-pH 参数与质子泵抑制剂治疗胃食管反流病诊断不明确患者的反应相关。
Aliment Pharmacol Ther. 2021 Aug;54(4):412-418. doi: 10.1111/apt.16481. Epub 2021 Jun 28.
7
Diagnostic approach to faecal incontinence: What test and when to perform?大便失禁的诊断方法：进行何种检查及何时进行？
World J Gastroenterol. 2021 Apr 21;27(15):1553-1562. doi: 10.3748/wjg.v27.i15.1553.
8
Translating Fecobionics Into a Technique That Addresses Clinical Needs for Objective Perineal Descent Measurements.将 Fecobionics 转化为一种能够满足客观会阴下降测量临床需求的技术。
Clin Transl Gastroenterol. 2021 Apr;12(4):e00342. doi: 10.14309/ctg.0000000000000342.
9
Advances and caveats in modern achalasia management.现代贲门失弛缓症治疗的进展与注意事项
Ther Adv Chronic Dis. 2021 Mar 12;12:2040622321993437. doi: 10.1177/2040622321993437. eCollection 2021.
10
Assessment and management of dysphagia and achalasia.吞咽困难和贲门失弛缓症的评估和管理。
Clin Med (Lond). 2021 Mar;21(2):119-123. doi: 10.7861/clinmed.2021-0069.
Zotero 插件